Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|September 29, 2010

PharmaVigilant Launches PaySite 2.0, A New Site Payment System

PharmaVigilant

today unveiled PaySite 2.0, a new Site Payment System that provides a complete dashboard to the sponsor, enabling them to program site payments based upon performance and individual site contracts. With PaySite, sponsors can determine payments made both graphically and within defined reports, and generate site letters defining the payouts and the criteria associated with the payment. Combined, this functionality streamlines the site payment process, improving the relationship between the sponsor and the site.
 
PaySite has no limitations regarding combinations; complex compensation programs can be easily defined and implemented in any currency. Information can be exported in sponsors’ accounting systems to further streamline the payment process.  
 
“One of the keys to enhancing site/sponsor relationships is paying sites on time. As sponsors’ accounting processes elongate in complexity and time, site payments get extended, creating stress on the relationship,” said James DeSanti, founder and chief executive officer, PharmaVigilant. “PaySite reduces the time upfront by creating payment reports on-demand, or with manual overrides when required.”


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.